- Home
- LPTH vs DAWN Comparison
LPTH vs DAWN Comparison
Compare LPTH & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- DAWN
- Stock Information
- Founded
- LPTH 1985
- DAWN 2018
- Country
- LPTH United States
- DAWN United States
- Employees
- LPTH N/A
- DAWN N/A
- Industry
- LPTH Semiconductors
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- DAWN Health Care
- Exchange
- LPTH Nasdaq
- DAWN Nasdaq
- Market Cap
- LPTH 377.5M
- DAWN 624.8M
- IPO Year
- LPTH 1996
- DAWN 2021
- Fundamental
- Price
- LPTH $8.68
- DAWN $7.44
- Analyst Decision
- LPTH Strong Buy
- DAWN Strong Buy
- Analyst Count
- LPTH 3
- DAWN 7
- Target Price
- LPTH $6.83
- DAWN $27.86
- AVG Volume (30 Days)
- LPTH 2.2M
- DAWN 1.4M
- Earning Date
- LPTH 11-13-2025
- DAWN 11-04-2025
- Dividend Yield
- LPTH N/A
- DAWN N/A
- EPS Growth
- LPTH N/A
- DAWN N/A
- EPS
- LPTH N/A
- DAWN N/A
- Revenue
- LPTH $37,202,630.00
- DAWN $187,638,000.00
- Revenue This Year
- LPTH $62.13
- DAWN $12.88
- Revenue Next Year
- LPTH $22.15
- DAWN $48.27
- P/E Ratio
- LPTH N/A
- DAWN N/A
- Revenue Growth
- LPTH 17.26
- DAWN 2190.50
- 52 Week Low
- LPTH $1.40
- DAWN $5.64
- 52 Week High
- LPTH $10.69
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- LPTH 56.71
- DAWN 48.63
- Support Level
- LPTH $7.84
- DAWN $6.90
- Resistance Level
- LPTH $9.19
- DAWN $7.86
- Average True Range (ATR)
- LPTH 0.96
- DAWN 0.37
- MACD
- LPTH -0.10
- DAWN -0.04
- Stochastic Oscillator
- LPTH 53.35
- DAWN 25.00
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.